跳至主要内容
临床试验/CTIS2024-511226-32-00
CTIS2024-511226-32-00进行中(未招募)1 期

Impact of prescribing nonsteroidal anti-inflammatory drugs in pleurodesis surgery after pneumothorax: a prospective randomized controlled double-blind multicenter noninferiority study

Centre Hospitalier Universitaire Amiens Picardie0 个研究点目标入组 358 人开始时间: 2024年4月22日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
358

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • Pneumothorax for video-exclusive surgical indication With or without minor lung resection (atypical resection), Age > or = 18 years old, Written or oral informed consent to participate in the study., Affiliation to a social security scheme, Highly effective contraception for women of childbearing age (combined hormonal contraception (estrogen and progesterone) combined with ovulation inhibition (oral, intra-vaginal, transdermal), hormonal contraception (progesterone only) combined with ovulation inhibition (oral, injectable, implantable), intrauterine device, hormone-releasing intrauterine system, bilateral fallopian tube occlusion, vasectomized partner, sexual abstinence, etc.). )

排除标准

  • Minor, Patient under guardianship, curatorship or deprived of liberty, patient who refuses to participate in the study, Contraindication to the use of NSAIDs, Contraindications to the use of TRAMADOL, Curative anticoagulation, Contraindications to the use of NEFOPAM, Contraindications to the use of PARACETAMOL, Contraindications to the use of SODIUM CHLORIDE, Lactose intolerance, Hemopneumothorax, Purulent pleurisy, Polytraumatized, Pregnant, parturient or breastfeeding patient

研究者

相似试验